ETI
ETI structure
|
Common Name | ETI | ||
|---|---|---|---|---|
| CAS Number | 13488-22-7 | Molecular Weight | 300.44 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 473.8±40.0 °C at 760 mmHg | |
| Molecular Formula | C20H28O2 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 221.9±22.0 °C | |
Use of ETI5,8,11-Eicosatriynoic acid (ETI) is a lipoxygenase inhibitor that blocks LTC4 biosynthesis in mast cell tumor cells[1]. |
| Name | 5,8,11-icosatriynoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | 5,8,11-Eicosatriynoic acid (ETI) is a lipoxygenase inhibitor that blocks LTC4 biosynthesis in mast cell tumor cells[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 473.8±40.0 °C at 760 mmHg |
| Molecular Formula | C20H28O2 |
| Molecular Weight | 300.44 |
| Flash Point | 221.9±22.0 °C |
| Exact Mass | 300.208923 |
| PSA | 37.30000 |
| LogP | 6.15 |
| Vapour Pressure | 0.0±2.5 mmHg at 25°C |
| Index of Refraction | 1.507 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| HS Code | 2916190090 |
|
~%
ETI CAS#:13488-22-7 |
| Literature: Recueil des Travaux Chimiques des Pays-Bas, , vol. 85, p. 1233 - 1250 |
|
~%
ETI CAS#:13488-22-7 |
| Literature: Recueil des Travaux Chimiques des Pays-Bas, , vol. 85, p. 1233 - 1250 |
|
~%
ETI CAS#:13488-22-7 |
| Literature: Recueil des Travaux Chimiques des Pays-Bas, , vol. 85, p. 1233 - 1250 |
| Precursor 2 | |
|---|---|
| DownStream 1 | |
CAS#:14602-39-2| HS Code | 2916190090 |
|---|---|
| Summary | 2916190090 unsaturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives。supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward)。VAT:17.0%。tax rebate rate:9.0%。MFN tariff:6.5%。general tariff:30.0% |
|
Nonsteroidal anti-inflammatory drugs, short-chain fatty acids, and reactive oxygen metabolism in human colorectal cancer cells.
Biochim. Biophys. Acta 1401(3) , 277-88, (1998) Nonsteroidal anti-inflammatory drugs (NSAIDs) and short-chain fatty acids are effective suppressors of colorectal cancer that may work in part by accentuating apoptosis of transformed cells. Since rea... |
|
|
Eicosatetraynoic and arachidonic acid-induced changes in cell membrane fluidity consonant with differences in computer-aided design-structures.
Biochim. Biophys. Acta 1105(2) , 285-90, (1992) ETYA (5,8,11,14-eicosatetraynoic acid), a competitive analogue of arachidonic acid (AA), inhibits the proliferation of U937 (human monoblastoid) and PC3 (human prostate) cancer cells, without the over... |
|
|
Chlamydia pneumoniae induces nitric oxide synthase and lipoxygenase-dependent production of reactive oxygen species in platelets. Effects on oxidation of low density lipoproteins.
Thromb. Haemost. 94(2) , 327-35, (2005) There is increasing evidence that Chlamydia pneumoniae is linked to atherosclerosis and thrombosis. In this regard, we have recently shown that C. pneumoniae stimulates platelet aggregation and secret... |
| Icosa-5,8,11-triynoic acid |
| MFCD00077343 |
| 5,8,11-Eicosatriynoic acid |
| 5,8,11-Icosatriynoic acid |